Cross-Linked Zwitterionic Surface Modifications for Biocompatible Blood-Contacting Medical Devices.

Area of Science:

• Biomaterials Science
• Surface Chemistry
• Medical Device Engineering

Background:

• Blood-contacting medical devices (e.g., catheters, artificial valves) are crucial for treating cardiovascular and renal diseases.
• Polymeric materials used in these devices are prone to adverse biological reactions like thrombosis, inflammation, and calcification, limiting their effectiveness and patient safety.

Purpose of the Study:

• To investigate the efficacy of plasma-mediated zwitterion surface modification with chemical cross-linking to enhance the stability and biocompatibility of medical devices.
• To evaluate the impact of cross-linked zwitterion grafts on biological responses, including thrombus formation, inflammation, and mineral deposition.

Main Methods:

• Development of a plasma-mediated zwitterion surface modification protocol incorporating chemical cross-linking.
• Optimization of the zwitterion to crosslinker ratio for improved graft stability without compromising functionality.
• Assessment of biological responses using in vitro models (thrombus formation, cytokine expression, calcification assays) and in vivo models (macrophage counts).
• Adaptation of the grafting process to vascular and valvular geometries.

Main Results:

• Cross-linked zwitterion grafts significantly reduced thrombus formation in both static and dynamic in vitro settings.
• Inflammatory responses were decreased, as evidenced by reduced inflammatory cytokine expression in vitro and lower M1 macrophage counts in vivo.
• Mineral deposition was significantly inhibited in in vitro calcification assays.
• The grafting technique was successfully applied to vascular and valvular geometries, demonstrating its versatility.

Conclusions:

• Chemical cross-linking of zwitterion grafts enhances their stability and effectively mitigates adverse biological responses on medical device surfaces.
• This advanced surface modification strategy shows significant potential for improving the safety and performance of a wide range of blood-contacting medical devices.